Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.

Pawlikowska, P; Tayoun, T; Oulhen, M; Faugeroux, V; Rouffiac, V; Aberlenc, A; Pommier, A L; Honore, A; Marty, V; Bawa, O; Lacroix, L; Scoazec, J Y; Chauchereau, A; Laplace-Builhe, C; Farace, F

Pawlikowska, P; Tayoun, T; Oulhen, M; Faugeroux, V; Rouffiac, V; Aberlenc, A; Pommier, A L; Honore, A; Marty, V; Bawa, O; Lacroix, L; Scoazec, J Y; Chauchereau, A; Laplace-Builhe, C; Farace, F.

Affiliation

Pawlikowska P; U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", INSERM, 94805, Villejuif, France.
Tayoun T; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Oulhen M; U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", INSERM, 94805, Villejuif, France.
Faugeroux V; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Rouffiac V; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Aberlenc A; U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", INSERM, 94805, Villejuif, France.
Pommier AL; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Honore A; Flow Cytometry and Imaging Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Marty V; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Bawa O; "Circulating Tumor Cells" Translational Platform, UMS AMMICa CNRS 3655-INSERM US23, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Lacroix L; Genomic Platform, CNRS UMS3655 - INSERM US23 AMMICA, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Scoazec JY; Experimental and Translational Pathology Platform, CNRS UMS3655 - INSERM US23 AMMICA, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Chauchereau A; Experimental and Translational Pathology Platform, CNRS UMS3655 - INSERM US23 AMMICA, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Laplace-Builhe C; Genomic Platform, CNRS UMS3655 - INSERM US23 AMMICA, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.
Farace F; Experimental and Translational Pathology Platform, CNRS UMS3655 - INSERM US23 AMMICA, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.

Sci Rep ; 10(1): 16876, 2020 10 09.

Article de En | MEDLINE | ID: mdl-33037240

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Tests de criblage d'agents antitumoraux / Carcinome pulmonaire non à petites cellules / Chorioallantoïde / Métastase tumorale / Antinéoplasiques Limites: Animals Langue: En Journal: Sci Rep Année: 2020 Type de document: Article Pays d'affiliation: France Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google